您的位置: 首页 > 农业专利 > 详情页

Human immunodeficiency virus replication inhibitors
专利权人:
VIIV Healthcare UK (No.5) Limited
发明人:
NAIDU, B. Narasimhulu,PATEL, Manoj,CONNOLLY, Timothy P.
申请号:
ES14727271
公开号:
ES2623904T3
申请日:
2014.03.13
申请国别(地区):
ES
年份:
2017
代理人:
摘要:
A compound of formula I or formula II ** Formula ** in which: R1 is -CON (R7) (Rs); or R1 is pyrrolyl, furanyl, thienyl, pyrazolyl, isoxazolyl, isothiazolyl, imidazolyl, oxazolyl, thiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, indolyl, benzofuranyl, benzothiophenyl, benzimidazolyl, or phenyl, and is substituted with 0-3 substituents, halo, alkyl, haloalkyl, alkenyl, alkoxy, alkenoxy, Ar1, (Ar1) alkyl, and (Ar1) O; R2 is hydrogen or alkyl; R3 is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, morpholinyl, homopiperidinyl, homopiperazinyl, or homomorpholinyl, and is substituted with 0-3 substituents selected from halo, alkyl, haloalkyl, hydroxyalkyl, alkoxyalkyl, alkenyl, cycloalkyl, hydroxy, alkoxy, haloalkoxy, alkenyloxy , and phenyl; or R3 is cycloalkyl, cycloalkenyl, chromanyl, oxacinyl, or dihydropyranoquinolinyl, and is substituted with 0-3 substituents selected from halo, alkyl, haloalkyl, hydroxyalkyl, alkoxyalkyl, alkenyl, cycloalkyl, hydroxy, alkoxy, haloalkoxy, alkenyloxy, and phenyl; R4 is alkyl or haloalkyl; R5 is alkyl; R6 is hydrogen or alkyl; R7 is Ar1 or (Ar1) alkyl; R8 is hydrogen or alkyl; Ar1 is phenyl or pyridinyl and is substituted with 0-3 substituents selected from halo, cyano, alkyl, haloalkyl, alkoxy, haloalkoxy, and alkenyloxy; x1 is -CONH-; or X1 is pyrrolyl, furanyl, thienyl, pyrazolyl, isoxazolyl, isothiazolyl, imidazolyl, oxazolyl, thiazolyl, triazolyl, oxadiazolyl, thiadiazolyl, benzimidazolyl, or phenyl; X2 is phenyl or benzyl and is substituted with 0-3 substituents selected from cyano, halo, alkyl, haloalkyl, alkoxy, and haloalkoxy; X3 is O or is absent; X4 is alkylene or alkenylene; X5 is O or is absent; and X6 is azetidinyl, pyrrolidinyl, piperidinyl, piperazinyl, morpholinyl, homopiperidinyl, homopiperazinyl, or homomorpholinyl, and is substituted with 0-3 halo or alkyl substituents; or a pharmaceutically acceptable salt thereof.Un compuesto de fórmula I o fórmula II**Fórmula** en las que: R1 es -CON(R7)(Rs); o R1 es pirroli
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充